Treatment of Dry Eye Syndrome with Orally Administered CF101-Reference-Cited by-同舟云学术

Treatment of Dry Eye Syndrome with Orally Administered CF101

Published:2010-07 Issue:7 Volume:117 Page:1287-1293
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Avni Isaac,Garzozi Hanna J.,Barequet Irina S.,Segev Fanni,Varssano David,Sartani Gil,Chetrit Noa,Bakshi Erez,Zadok David,Tomkins Oren,Litvin Gilad,Jacobson Kenneth A.,Fishman Sari,Harpaz Zivit,Farbstein Motti,Yehuda Sara Bar,Silverman Michael H.,Kerns William D.,Bristol David R.,Cohn Ilan,Fishman Pnina

Publisher

Elsevier BV

Subject

Ophthalmology

Reference34 articles.

1. Dry eyes: etiology and management;Latkany;Curr Opin Ophthalmol,2008

2. Update in Sjögren's syndrome;Fox;Curr Opin Rheumatol,2000

3. The definition and classification of dry eye disease report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007);Ocul Surf,2007

4. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface;Luo;Invest Ophthalmol Vis Sci,2004

5. Inflammatory markers in the tears of patients with ocular surface disease;Acera;Ophthalmic Res,2008

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current approaches for the regeneration and reconstruction of ocular surface in dry eye;Frontiers in Medicine;2022-09-23

2. Placebo administration for dry eye disease: a level I evidence based systematic review and meta-analysis;International Journal of Clinical Pharmacy;2022-08-08

3. Intraocular implants loaded with A3R agonist rescue retinal ganglion cells from ischemic damage;Journal of Controlled Release;2022-03

4. Targeting purinergic receptors to attenuate inflammation of dry eye;Purinergic Signalling;2022-02-26

5. CF101 alleviates OA progression and inhibits the inflammatory process via the AMP/ATP/AMPK/mTOR axis;Bone;2022-02